Velesco Pharmaceutical Services brings the benefits of understanding the challenges faced during the drug development process.
Velesco was formed in 2007 by former Pfizer Michigan Research & Development (Pharmaceutical Science) colleagues. Velesco’s founders are analytical chemists with drug formulation and manufacturing experience, and decades of experience in both early phase and later phase drug development. This team of pharmaceutical industry veterans was trained at various top pharmaceutical companies with research and development facilities that were located in Michigan, including such legacy companies as Pfizer, Warner Lambert, Parke Davis, Upjohn and Pharmacia, among others.
Velesco operates from state-of-the-art facilities and has maintained a focus on providing early phase drug formulation, analytical method development and cGMP clinical supply materials to small to mid-sized biotech and pharmaceutical companies. We have an experienced team who has worked on over 200 drug development programs and is eager to assist our clients, both returning and new!
News and Events
Lisa Crandall, MS, and Peter Angus, PhD, spoke with Pharmaceutical Technology about the best practices in stability testing. Read the interview here.
Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group. Read the press release here.
CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing!
2 new job postings! Careers
Velesco's work published
Formulation Development & Manufacturing:
Using a Single Provider Reduces Costs & Risk
Read it here.